Skip NavigationSkip to Content

High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells

  1. Author:
    Zhao, Xi-Long
    Lin, Yong
    Jiang, Jun
    Tang, Zhuo
    Yang, Shuai
    Lu, Lu
    Liang, Yan
    Liu, Xue
    Tan, Jiao
    Hu, Xu-Gang
    Niu, Qin
    Fu, Wen-Juan
    Yan, Ze-Xuan
    Guo, De-Yu
    Ping, Yi-Fang
    Wang, Jiming
    Zhang, Xia
    Kung, Hsiang-Fu
    Bian, Xiu-Wu [ORCID]
    Yao, Xiao-Hong
  2. Author Address

    Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, China., Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, China., Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.,
    1. Year: 2017
    2. Date: Nov
    3. Epub Date: 2017 Aug 12
  1. Journal: Journal of Pathology
    1. 243
    2. 3
    3. Pages: 376-389
  2. Type of Article: Article
  1. Abstract:

    Cancer stem/initiating cells (CSCs/CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer associated fibroblasts (CAFs) are major components of the niche of breast cancer initiating cells (BCICs) and their interactions may profoundly affect breast cancer progression. Autophagy has been considered as a critical process for CIC maintenance, but whether it is involved in the cross-talk between CAFs and CICs to affect tumourigenesis and pathological significance remains elusive. In this study, we found that the presence of CAFs containing high levels of LC3II, a maker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high-mobility group box 1 (HMGB1) that activated its receptor TLR4 expressed by luminal breast cancer cells to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through a HMGB1/TLR4 axis, and both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets. This article is protected by copyright. All rights reserved.

    See More

External Sources

  1. DOI: 10.1002/path.4958
  2. PMID: 28802057
  3. WOS: 000413150600011

Library Notes

  1. Fiscal Year: FY2016-2017
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel